[
  {
    "ts": "2025-04-18T03:01:54+00:00",
    "headline": "Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025",
    "summary": "We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide […]",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-inc-030154003.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "1cc7ad96-29b7-337c-a389-361f312288d4",
      "content": {
        "id": "1cc7ad96-29b7-337c-a389-361f312288d4",
        "contentType": "STORY",
        "title": "Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025",
        "description": "",
        "summary": "We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide […]",
        "pubDate": "2025-04-18T03:01:54Z",
        "displayTime": "2025-04-18T03:01:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/d86e035b8a686f5822cdb2038c2734bd",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V38MKvpV7rtxUXdqTKaAEg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/d86e035b8a686f5822cdb2038c2734bd.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XEE8VwVx1p5m7wo5Bhpftw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d86e035b8a686f5822cdb2038c2734bd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-inc-030154003.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-inc-030154003.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            },
            {
              "symbol": "COMP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]